Table 1.
Patient cohort description.
| Overall ACC cohort n (%) |
Gene expression study ACC cohort n (%) |
|
|---|---|---|
| Number of patients | 83 (100%) | 46 (55%) |
| Gender | ||
| Female | 56 (67) | 35 (76) |
| Male | 27 (33) | 11 (24) |
| Age at presentation (years) | ||
| Median | 53.5 | 51.0 |
| Range | (21–85) | (21–85) |
| pT | ||
| pT1 | 10 (12) | 5 (11) |
| pT2 | 6 (7) | 3 (7) |
| pT3 | 14 (17) | 10 (22) |
| pT4 | 50 (60) | 27 (59) |
| Miss | 3 | 1 |
| pN | ||
| − | 73 (88) | 41(89) |
| + | 10 (12) | 5 (11) |
| ENE | ||
| − | 3 (30) | 2 (40) |
| + | 7 (70) | 3 (60) |
| Grade | ||
| I–II | – | 35 (76) |
| III | – | 11 (24) |
| Site | ||
| Major | 22 (26) | 14 (30) |
| Minor | 61 (74) | 32 (70) |
| Adjuvant RT | ||
| No | 15 (18) | 12 (26) |
| Yes | 67 (81) | 33 (72) |
| Miss | 1 | 1 |
| Recurrence at last follow up | ||
| No | 41 (49) | 19 (41) |
| Yes | 42 (51) | 27 (59) |
| Dead at last follow up | ||
| No | 54 (65) | 29 (63) |
| Yes | 29 (35) | 17 (37) |
ENE extra nodal extension, RT radiotherapy, N lymph node.